Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,814.82
3,455.47
3,277.25
2,973.09
2,667.27
2,309.51
2,133.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,814.82
3,455.47
3,277.25
2,973.09
2,667.27
2,309.51
2,133.22
Raw Material Cost
804.03
877.42
915.56
863.05
722.89
572.60
520.34
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
540.20
372.41
390.58
336.94
13,362.04
310.09
322.58
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.73
0.71
0.59
1.36
2.14
1.39
10.26
Selling and Distribution Expenses
2,025.26
1,751.18
1,665.27
1,596.84
1,477.11
1,317.33
1,201.81
Other Expenses
-38.18
-25.43
-29.40
-22.46
-1,328.53
-22.18
-26.01
Total Expenditure (Excl Depreciation)
2,988.37
2,747.39
2,677.97
2,573.60
2,278.86
1,979.58
1,794.91
Operating Profit (PBDIT) excl Other Income
826.5
708.1
599.3
399.5
388.40000000000003
329.90000000000003
338.29999999999995
Other Income
64.67
103.48
68.54
81.59
22.76
37.65
36.83
Operating Profit (PBDIT)
988.10
902.38
738.15
547.98
476.25
433.55
435.42
Interest
0.73
0.71
0.59
1.36
2.14
1.39
10.26
Exceptional Items
-7.10
0.31
-1.62
6.13
-2.57
-28.16
-8.25
Gross Profit (PBDT)
3,010.79
2,578.06
2,361.69
2,110.04
1,944.39
1,736.91
1,612.87
Depreciation
101.29
76.23
82.51
79.06
76.72
73.03
69.90
Profit Before Tax
878.98
825.75
653.43
473.68
394.83
330.97
347.02
Tax
117.02
104.99
84.93
51.73
50.85
39.82
48.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
759.50
722.55
568.11
465.30
361.54
325.49
294.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
759.50
722.55
568.11
465.30
361.54
325.49
294.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.94
0.03
0.01
0.00
0.96
-1.11
-1.29
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
762.45
722.58
568.12
465.30
362.50
324.38
293.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,400.58
3,072.53
2,791.04
2,550.81
2,278.99
2,312.72
2,209.89
Earnings per share (EPS)
1.34
1.28
1.0
0.82
0.65
0.57
0.51
Diluted Earnings per share
1.34
1.28
1.0
0.82
0.65
0.57
0.51
Operating Profit Margin (Excl OI)
21.55%
20.91%
17.91%
13.03%
14.13%
13.98%
15.41%
Gross Profit Margin
25.7%
26.1%
22.46%
18.59%
17.68%
17.49%
19.54%
PAT Margin
19.91%
20.91%
17.33%
15.65%
13.55%
14.09%
13.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 10.40% vs 5.44% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 5.51% vs 27.20% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 15.58% vs 19.31% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs 16.67% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Henan Lingrui Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
3,814.82
0
3,814.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,814.82
0
3,814.82
Raw Material Cost
804.03
0
804.03
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
540.20
0
540.20
Power Cost
0
0
0.00
Manufacturing Expenses
0.73
0
0.73
Selling and Distribution Expenses
2,025.26
0
2,025.26
Other Expenses
-38.18
0.00
-38.18
Total Expenditure (Excl Depreciation)
2,988.37
0
2,988.37
Operating Profit (PBDIT) excl Other Income
826.45
0.00
826.45
Other Income
64.67
0
64.67
Operating Profit (PBDIT)
988.10
0
988.10
Interest
0.73
0
0.73
Exceptional Items
-7.10
0
-7.10
Gross Profit (PBDT)
3,010.79
0
3,010.79
Depreciation
101.29
0
101.29
Profit Before Tax
878.98
0
878.98
Tax
117.02
0
117.02
Provisions and contingencies
0
0
0.00
Profit After Tax
759.50
0
759.50
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
759.50
0
759.50
Share in Profit of Associates
0
0
0.00
Minority Interest
2.94
0
2.94
Other related items
0.00
0.00
0.00
Consolidated Net Profit
762.45
0
762.45
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,400.58
0
3,400.58
Earnings per share (EPS)
1.34
0
1.34
Diluted Earnings per share
1.34
0
1.34
Operating Profit Margin (Excl OI)
21.55%
0%
0.00
21.55%
Gross Profit Margin
25.70%
0%
0.00
25.70%
PAT Margin
19.91%
0%
0.00
19.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 381.48 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.40% vs 5.44% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 76.24 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.51% vs 27.20% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 92.34 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 15.58% vs 19.31% in Dec 2024
Annual - Interest
Interest 0.07 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs 16.67% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.55%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






